BD-221

N/A

Report date: 2023/10/26 16:50:42

Base Information

Drug NameBD-221
Drug Alias NameBD-221
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Lentiviral vector
Mechanisms of ActionGene modulators
TargetsUpdating
Therapy Area/IndicationsAnemia, Hemolytic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai BDgene Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai BDgene Co Ltd
Inactive CompaniesN/A
Active IndicationsAnemia, Hemolytic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A